Organization
Neuramedy
1 clinical trial
Clinical trial
A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of NM-101 in Healthy Male and Female SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-05-30